RED DEER, AB, APRIL 6, 2021 – Stigma Grow (“Stigma” or the “Company”) and its parent company, CanadaBis Capital Inc. (TSX-V:CANB), are thrilled to announce they have entered into a third-party production agreement (the “Agreement”) with Sundial Growers Inc. (NASDAQ: SNDL) (“Sundial” or the “Company”), a Health Canada licensed cannabis producer recognized for its ‘small-batch-at-scale’ individualized ‘room’ approach, to produce a variety of Sundial’s hydrocarbon (BHO) concentrates.
Among other opportunities within the concentrates market, the new collaboration between the two Alberta-based companies will enable capitalization on the fast-emerging live-resin vape market.
Under the terms of the Agreement, Sundial will provide its input for both fresh-frozen and cured formats to Stigma to produce a variety of live-resin and cured cannabis concentrates.
Sundial expects to launch the products across Canada under the Top Leaf brand in Q3 2021.
“As one of the first-to-market producers of true live-resin, high-terpene, full-spectrum vape cartridges in Alberta we reviewed many partnership requests from some of legal cannabis’ most recognizable brands, but none provided the brand and business fit demonstrated by Sundial,” said Travis McIntyre, CEO of Stigma. “We look forward to working with this well-established Alberta brand long into the future and recognize the value that comes to those who partner strategically with like-minded visionaries.”
“As part of our continued focus within the premium inhalable segment, we are pleased to enter into a concentrates partnership with Stigma,” added Andrew Stordeur, President and Chief Operating Officer of Sundial. “We believe this collaboration will provide our consumers with an excellent addition to our portfolio of cannabis products.”
In addition to this partnership announcement, the first two months of 2021 has seen the Company’s existing and new products accepted into Ontario, British Columbia, Manitoba and Saskatchewan, as education surrounding the quality and experience offered by live-resin concentrates makes its way across the country to millions of recreational and medicinal consumers typically looking for something new and improved.
About CanadaBis Capital Inc. & Stigma Grow
CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the global cannabis market – with specific attention paid to supplying the fast-emerging concentrates category through their Stigma Grow cultivation and extraction facility.
Acting as the cornerstone for everything they offer, Stigma Grow continuously strives to address the market demands and lingering stigmas within the legal cannabis industry head-on, with products designed to disturb the status quo and dramatically shift the conversation surrounding Canada’s legal cannabis industry.
For more information on CanadaBis Capital or Stigma Grow visit:
Investor Relations Info@CanadaBis.com 1-888-STIGMA1
About Sundial Growers Inc.
Sundial is a public company with Common Shares traded on Nasdaq under the symbol “SNDL”.
Sundial is a licensed producer that crafts cannabis using state-of-the-art indoor facilities. Our ‘craft-at-scale’ modular growing approach, award-winning genetics and experienced growers set us apart.
Our Canadian operations cultivate small-batch cannabis using an individualized “room” approach, with 448,000 square feet of total available space.
Sundial’s brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Our consumer-packaged goods experience enables us to not just grow quality cannabis, but also to create exceptional consumer and customer experiences.
We are proudly Albertan, headquartered in Calgary, AB, with operations in Olds, AB, and Rocky View County, AB.